Allogene Therapeutics, Inc. ($ALLO)
Filing Information
| Accession Number | 0001851044-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 23, 2026 |
| Document Date | Jan 21, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
26,269
Total Value
$40,979.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP of R&D | Common Stock | โ | Jan 21, 2026 | Sale | 26,269 | $1.56 | $40,979.64 | 616,866 | Direct | โ | View Details |